Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0552
F

Failure to Obtain and Document Informed Consent for Psychoactive Medications and Bed Alarms

Bakersfield, California Survey Completed on 04-24-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to follow its own policies and procedures regarding informed consent for psychoactive/psychotropic medication use and the use of bed alarms for multiple residents. In several cases, consent forms for psychoactive medications such as escitalopram, amitriptyline, alprazolam, venlafaxine, bupropion, sertraline, Seroquel, lorazepam, and clonazepam were either missing required physician signatures, lacked verification by a licensed nurse, or were not signed by the resident or their responsible party. In some instances, documentation of informed consent was entirely absent, despite the medications being administered. The facility's policy required that the prescribing clinician obtain and document informed consent, and that a licensed nurse verify and sign the consent form prior to medication administration, but these steps were not consistently followed. The report details that for several residents, including those with varying levels of cognitive impairment as measured by the Brief Interview for Mental Status (BIMS), informed consent forms were incomplete or missing. For example, one resident with a BIMS of 12 had consent forms for two psychoactive medications that were not signed by a physician. Another resident with a BIMS of 3 had an incomplete consent for alprazolam, and a resident with a BIMS of 7 had no documentation of consent for lorazepam, despite receiving the medication on multiple occasions. In other cases, the responsible party's signature was present, but there was no verification by a nurse or physician, as required by policy. Additionally, the facility failed to obtain and document informed consent for the use of bed alarms for two residents. The consent forms for these interventions were incomplete, lacking signatures from a nurse or physician, and in one case, the responsible party's signature was not clearly documented. The facility's policy required that the physician provide education to the resident or responsible party about the risks, benefits, and alternatives of such interventions, and that informed consent be properly documented, but this was not done consistently.

An unhandled error has occurred. Reload 🗙